Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 24 Jan 2022 |
2 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 21 Mar 2022 |
3 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 12 Apr 2022 |
4 | Reply to Exam Report (MIS-R) | 13 Apr 2022 |
5 | Authorization Letter | 10 Jul 2023 |
6 | Documents in support of Show cause Hearing (SCH) | 14 Jul 2023 |
1 | EXAMINATION REPORT | 13192685 | 16 Mar 2022 | |
2 | Hearing Notice (Show Cause) | 15413274 | 13 Jun 2023 | |
3 | Hearing Notice (Show Cause) | 15692716 | 25 Jul 2023 | |
4 | Tribunal Refused Notice for : 5297496 | 15878828 | 6141091 | 21 Aug 2023 |
The application for Celltriaxon was made on 24 January 2022.
The trademark applicant for Celltriaxon is STRIDES PHARMA SCIENCE.
Celltriaxon is applied in class(es) 5.
Application for Celltriaxon is on Refused stage.
Application Id allotted to Celltriaxon is 5297496.
Trademark agent or attorney for the application is Altacit Global.
Celltriaxon filed with the Intellectual property office as a WORD.